Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26F96V5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,003
Award facts
- Contract value 100% obligated
- $16,003.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,003.31 to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 mL pens on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031, serving as the primary vehicle for pharmaceutical and medical supply procurement to support military healthcare programs globally.
AmerisourceBergen Drug Corp operates as a major pharmaceutical distributor providing critical medical commodities to federal agencies, particularly the Defense Health Agency and military treatment facilities. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. This delivery order for Wegovy, a GLP-1 receptor agonist diabetes medication, aligns with AmerisourceBergen's established role as a key vendor in the federal medical procurement supply chain, fulfilling the Defense Logistics Agency's pharmaceutical support requirements for military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F96V5?
SPE2DR26F96V5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F96V5 worth?
The government has obligated $16,003 on SPE2DR26F96V5.
Is contract SPE2DR26F96V5 an order under another contract?
Yes. SPE2DR26F96V5 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F96V5 competed?
The extent of competition for SPE2DR26F96V5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award